CRIS Current Research Information System

ROBUSTELLI, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.113
NA - Nord America 3.001
EU - Europa 2.224
AF - Africa 209
SA - Sud America 132
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 8.690
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.964
VN - Vietnam 1.033
SG - Singapore 799
CN - Cina 639
GB - Regno Unito 486
IT - Italia 372
SE - Svezia 286
DE - Germania 278
HK - Hong Kong 192
FR - Francia 149
IN - India 130
NL - Olanda 126
RU - Federazione Russa 92
BR - Brasile 89
IE - Irlanda 78
CH - Svizzera 73
FI - Finlandia 70
JP - Giappone 63
KR - Corea 59
TG - Togo 50
CI - Costa d'Avorio 47
ZA - Sudafrica 46
BG - Bulgaria 37
EE - Estonia 36
NG - Nigeria 31
UA - Ucraina 31
JO - Giordania 30
BE - Belgio 26
TH - Thailandia 25
PH - Filippine 24
CA - Canada 23
AR - Argentina 18
PL - Polonia 18
SC - Seychelles 18
IQ - Iraq 17
AT - Austria 16
BD - Bangladesh 16
ID - Indonesia 14
ES - Italia 12
TR - Turchia 12
GR - Grecia 11
IR - Iran 9
MX - Messico 9
TW - Taiwan 9
UZ - Uzbekistan 9
PK - Pakistan 7
PY - Paraguay 6
AU - Australia 5
EC - Ecuador 5
CO - Colombia 4
DZ - Algeria 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CL - Cile 3
EU - Europa 3
LT - Lituania 3
MK - Macedonia 3
PE - Perù 3
QA - Qatar 3
VE - Venezuela 3
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
EG - Egitto 2
ET - Etiopia 2
HR - Croazia 2
IL - Israele 2
KE - Kenya 2
KZ - Kazakistan 2
LV - Lettonia 2
MA - Marocco 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
SA - Arabia Saudita 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BO - Bolivia 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
HU - Ungheria 1
JM - Giamaica 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MT - Malta 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TM - Turkmenistan 1
TN - Tunisia 1
Totale 8.688
Salva come PNG Salva come JPEG
Città #
Singapore 571
Southend 436
Ashburn 381
Chandler 328
Dong Ket 235
San Jose 188
Ho Chi Minh City 182
Hong Kong 177
Fairfield 164
Hanoi 153
Dallas 119
Ann Arbor 118
Beijing 113
Houston 112
Woodbridge 98
Wilmington 89
Princeton 84
Dublin 78
Seattle 78
Hefei 74
Bologna 72
Santa Clara 72
Boardman 66
Cambridge 64
Bern 58
Helsinki 54
Tokyo 52
Lomé 50
Seoul 50
Abidjan 47
New York 47
Lauterbourg 46
Nanjing 43
Munich 38
Westminster 38
Sofia 37
Medford 34
Padova 34
Amman 29
Frankfurt am Main 29
Los Angeles 29
Haiphong 28
Abeokuta 27
Bremen 27
Brussels 25
Milan 25
Berlin 23
Redmond 23
Buffalo 22
Rome 21
Guangzhou 19
Da Nang 18
Redwood City 18
Redondo Beach 17
Jinan 15
Paris 15
Saint Petersburg 15
Council Bluffs 14
London 14
Nanchang 14
Shenyang 14
Hải Dương 13
São Paulo 13
Changsha 12
Turku 12
Amsterdam 11
Baghdad 11
Florence 11
Hebei 11
Mountain View 11
Atlanta 10
Biên Hòa 10
Shanghai 10
Vienna 10
Warsaw 10
Bangkok 9
Falkenstein 9
Falls Church 9
Johannesburg 9
Orem 9
Tianjin 9
Bengaluru 8
Chicago 8
Jakarta 8
Montreal 8
Orlando 8
San Diego 8
Turin 8
Zurich 8
Athens 7
Fuzhou 7
Monmouth Junction 7
Norwalk 7
Augusta 6
Des Moines 6
Hangzhou 6
Leawood 6
Pune 6
Stockholm 6
Wuhan 6
Totale 5.504
Salva come PNG Salva come JPEG
Nome #
Adult "Triple Negative" ACUTE Lymphoblastic Leukemia Genome Wide Characterization 314
Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia 276
The alteration in key regulator genes of autophagy is mainstream mechanism of therapy resistance and impact prognosis of acute myelogenous leukemia (AML): results from diagnosis genomic analysis on 148 consecutive patients treated with intensive chemotherapy and long-term survival follow-up 255
Blinatumomab Is Safe and Effective in Relapsed and MRD Positive B-ALL CD19+ Patients: The Bologna Compassionate Program Experience 253
Alterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML) 248
Adult B-Cell Precursor Acute Lymphoblastic Leukemia (BC-ALL) Negative For Recurrent Fusion Genes Are Characterized By a High Complex Genetic Heterogeneity Influencing Prognosis 242
Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia 236
Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia 232
Novel and rare fusion transcripts involving transcription factors and tumor suppressor genes in acute myeloid leukemia 231
First Report of the Gimema LAL1811 Phase II Prospective Study of the Combination of Steroids with Ponatinib As Frontline Therapy of Elderly or Unfit Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia 209
Distinct pattern of alterations in tp53 mutated and wild type acute myeloid leukemia (AML) patients 208
Clustering Adult ACUTE Lymphoblastic Leukemia (ALL) Philadelphia Negative (Ph-) By Whole Exome Sequencing (WES) Analysis 208
Copy number variants signature in two patients with relapsed acute promyelocytic leukemia 204
Identification of Two DNMT3A Mutations Compromising Protein Stability and Methylation Capacity in Acute Myeloid Leukemia 202
Deficient necroptosis pathway as a negative prognostic factor in acute myeloid leukemia. 200
Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia 194
Microarray analysis to identifiy novel copy number alterations in acute myeloid leukemia 192
MHC-I Antigen Presentation Role in Immune Escape of Acute Myeloid Leukemia with High Burden of Genomic Aberration 190
Survival analysis of patients carrying different FLT3 mutations (internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations) in 459 consecutive non M3 newly diagnosed acute myeloid leukemia (AML) 188
DEEP MOLECULAR CHARACTERIZATION OF ADULT B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (BC-ALL) NEGATIVE FOR RECURRENT FUSION GENES REVEALS A HIGH COMPLEX GENETIC HETEROGENEITY INFLUENCING PROGNOSIS 187
The synergistic efficacy of Chk1/Chk2 inhibitors and doxorubicin in the treatment of acute lymphoblastic leukemia 184
Ponatinib Is Well Tolerated and Active In Patients With Relapsed/Refractory Philadelphia Positive Acute Lymphoblastic Leukemia (PH+ ALL) and Advanced Phase Of Chronic Myelogenous Leukemia (CML) Harbouring T315I Mutation: The Bologna Experience 179
Enhance the Efficacy of Doxorubicin Destabilizing the G2/M Checkpoint with a CHK1/CHK2 Inhibitor Pre-Treatment on Acute Lymphoblastic Leukemia 178
Very Poor Outcome and Chemoresistance of Acute Myeloid Leukemia Patients with TP53 Mutations: Correlation with Complex Karyotype and Clinical Outcome 178
Prognostic significance of alterations of pathways regulating autophagy in acute myeloid leukemia 175
RNA Sequencing Reveals Novel and Rare Fusion Transcripts in Acute Myeloid Leukemia 174
TP53 mutations are mutually exclusive with FLT3 and NPM mutations in AML patients and are strongly associated with complex karyotype and poor outcome 174
Override the doxorubicin-induced G2/M checkpoint using cell-cycle checkpoint inhibitors on acute lymphoblastic leukemia 169
NEXT GENERATION SEQUENCING FOR MINIMAL RESIDUAL DISEASE MEASUREMENT IN THE DAILY CLINICAL MANAGEMENT OF PH-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS IS FEASIBLE AND PROVIDES USEFUL CLINICAL DATA. 165
Ex vivo characterization of acute myeloid leukemia patients undergoing hypomethylating agents and venetoclax regimen reveals a venetoclax-specific effect on non-suppressive regulatory T cells and bona fide PD-1+TIM3+ exhausted CD8+ T cells 164
The Inhibition of Checkpoint Kinase 1 As a Promising Strategy to Increase the Effectiveness of Different Treatments in Acute Lymphoblastic Leukemia 163
Tp53 mutation screening in adult acute myeloid leukemia (AML) patients shows a strong association with complex karyotype and poor outcome 158
Very poor outcome and chemoresistance of acute myeloid leukemia patients with TP53 mutations: Correlation with complex karyotype and clinical outcome 158
You have accessAlterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML) 157
You have accessMine the Stability of the G2/M Checkpoint to Break Down Acute Lymphoblastic Leukemia Defenses Against Antineoplastic Drugs 157
COMPLEX GENETIC HETEROGENEITY INFLUENCES PROGNOSIS IN ADULT B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA NEGATIVE FOR RECURRENT FUSION GENES 156
Novel fusion transcripts identified by RNAseq cooperate with somatic mutations in the pathogenesis of acute myeloid leukemia 154
Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant 154
Tracking Response and Resistance in Acute Myeloid Leukemia through Single-Cell DNA Sequencing Helps Uncover New Therapeutic Targets 150
DEREGULATED EXPRESSION OF CHECKPOINT KINASE 1 (CHK1) IN BCR-ABL-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (BCR-ABL+ ALL) SUGGESTS A NEW THERAPEUTIC TARGET 150
Leukemia Associated TP53 Mutations in AML Patients ARE Strongly Associated with Complex Karyotype and Poor Outcome 150
Synergism through WEE1 and CHK1 inhibition in acute lymphoblastic leukemia 145
INCB84344-201: Ponatinib and steroids in frontline therapy of unfit patients with Ph+ acute lymphoblastic leukemia 145
Ponatinib is well tolerated and active in patients with relapsed/refractory philadelphia positive leukemias: The Bologna experience 140
Emergence and Cytogenetic Clonal Evolution of Chromosome 7 Abnormalities in Myeloid Malignancies: Investigating the Role of Telomere Dysfunction 137
Adrenomedullin Expression Characterizes Leukemia Stem Cells and Associates With an Inflammatory Signature in Acute Myeloid Leukemia 132
Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment 121
COMPARISON BETWEEN NGS IGH/TCR AND RT-PCR BCR::ABL1 MINIMAL RESIDUAL DISEASE IN PH+ ACUTE LYMPHOBLASTIC LEUKEMIA: A PRELIMINARY ANALYSIS 111
Totale 8.847
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.105
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.105
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021396 0 0 0 0 0 0 0 0 0 0 45 351
2021/2022970 123 24 44 90 95 43 13 66 36 61 194 181
2022/20231.207 128 166 62 163 108 92 29 54 200 34 80 91
2023/2024327 10 38 22 37 24 82 19 42 12 11 10 20
2024/20251.193 45 164 101 91 96 33 109 52 17 155 71 259
2025/20263.085 272 332 223 206 303 143 326 125 830 261 64 0
Totale 8.847